Cleared Traditional

K112020 - SYNGO.CT VASCULAR ANALYSIS

K112020 is the FDA 510(k) clearance for SYNGO.CT VASCULAR ANALYSIS by Siemens Medi Cal Solutions, Inc.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K112020 · Siemens Medi Cal Solutions, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2011
Decision
35d
Days
Class 2
Risk

K112020 is an FDA 510(k) clearance for the SYNGO.CT VASCULAR ANALYSIS. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Siemens Medi Cal Solutions, Inc. (Mavern, US). The FDA issued a Cleared decision on August 18, 2011 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Siemens Medi Cal Solutions, Inc. devices

Submission Details

510(k) Number K112020 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2011
Decision Date August 18, 2011
Days to Decision 35 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 107d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Tuv Sud America, Inc.

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 604
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K112020.
SAFIRE
K103424 · Siemens Medical Solutions USA, Inc. · Nov 2011
GE VEO RECONSTRUCTION OPTION
K103489 · General Electric Co. · Sep 2011
AQUILION LB MOVEMENT BASE KIT
K111633 · Toshiba America Medical Systems, In.C · Aug 2011
OPTIMA CT660
K110227 · Ge Medical Systems, LLC · Jul 2011
DISCOVERY MODEL CT590 RT AND OPTIMA MODEL CT580 CT SYSTEMS
K093581 · Ge Medical Systems, LLC · Apr 2011
SCENARIA WHOLE-BODY X-RAY CT SYSTEM
K101888 · Hitachi Medical Systems America, Inc. · Apr 2011